Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Seneca Growth Capital VCT Plc (HYG) Ordinary 1p

Sell:20.00p Buy:24.00p 0 Change: No change
Market closed Prices as at close on 18 October 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:20.00p
Buy:24.00p
Change: No change
Market closed Prices as at close on 18 October 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:20.00p
Buy:24.00p
Change: No change
Market closed Prices as at close on 18 October 2019 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

The objective of Company has to date been to provide shareholders with an attractive income and capital return by investing its funds in a portfolio of unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules. The Company targets well managed businesses with strong leadership, that can demonstrate established and proven concepts, and are seeking an injection of growth capital to support their continued development.

Top 10 holdings currently unavailable.

Top 10 sectors currently unavailable.

Top 10 countries currently unavailable.

Fee Structure

The company is managed by the Board of Directors. A performance fee of 10% is payable if dividends and capital distributions exceed the sum of 80GBX per share, which is the gross subscription of 100GBX less 20GBX income tax deemed by the Board.

Dividend Policy

The Directors expect to pay a final dividend each year. In the short term, dividend payments are restricted by the limited income generated by the investment portfolio of Company. It is expected, in due course, the Company will realise capital growth on the disposal of successful investments and distribute these to shareholders.

ASSET SPLIT

Total number of holdings: 14.

Trust Manager

Not Disclosed

Manager Bio

Not currently available for this investment trust.

Board Of Directors

John Hustler Chairman, Richard Roth, Richard Manley

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.